Mohr, Andrea <br/><br/>
Targeting of XIAP combined with systemic mesenchymal stem cell-mediated delivery of sTRAIL ligand inhibits metastatic growth of pancreatic carcinoma cells.  [electronic resource] 

 -  Stem cells (Dayton, Ohio)  Nov 2010 
 - 2109-20 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1549-4918 
<br/><br/><label>Standard No.: </label>10.1002/stem.533  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Apoptosis--physiology<br/>Blotting, Western<br/>Cell Differentiation<br/>Cell Line, Tumor<br/>Enzyme-Linked Immunosorbent Assay<br/>Humans<br/>Mesenchymal Stem Cells--metabolism<br/>Mice<br/>Mice, Nude<br/>Pancreatic Neoplasms--therapy<br/>TNF-Related Apoptosis-Inducing Ligand--genetics<br/>X-Linked Inhibitor of Apoptosis Protein--genetics